Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Omair Iqbal
Institution:
Medical College of Wisconsin
Observed institutions:
Medical College of Wisconsin,
Case Western Reserve University
ORCID:
0009-0006-0703-7027
Observed ORCID:
0009-0006-0703-7027
OpenAlex ID:
A5058770424
Dual targeting of EZH2 and androgen receptor as a novel therapy for castration-resistant prostate cancer
2020
·
Eswar Shankar
, Daniel Franco
, et al.
·
Toxicology and Applied Pharmacology
·
28
Novel approach to therapeutic targeting of castration-resistant prostate cancer
2020
·
Eswar Shankar
, Daniel Franco
, et al.
·
Medical Hypotheses
·
9
Coronary artery calcium score for cardiovascular risk assessment in inflammatory bowel disease – Data from first pilot prospective study
2024
·
Omair Iqbal
, Harini Shah
, et al.
·
Digestive and Liver Disease
·
3
S1073 Inflammatory Bowel Disease is Associated With Increased Risk of Cardiovascular Events but Not Mortality. Data From a Large U.S. National Database
2024
·
Saffia Bajwa
, Paraj Patel
, et al.
·
The American Journal of Gastroenterology
·
1
718 Biologics and Jak Inhibitors Decrease Major Cardiovascular Events (mace) in Ibd Patients. Data From a Large National Cohort. Is It the Mechanism of the Drug or Control of Disease?
2024
·
Paraj Patel
, Omair Iqbal
, et al.
·
Gastroenterology
·
1
Safety of biologics and Janus kinase inhibitors in inflammatory bowel disease patients with low cardiovascular risk
2026
·
Paraj Patel
, Omair Iqbal
, et al.
·
Crohn s & Colitis 360
Mo1898: INCREASED RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IS PRIMARILY DRIVEN BY PRESENCE OF CARDIOVASCULAR RISK FACTORS AND PRIOR CORONARY ARTERY DISEASE.
2025
·
Paraj Patel
, Omair Iqbal
, et al.
·
Gastroenterology
Mo1806 ANTI TNF MEDICATIONS BUT NOT JAK INHIBITORS ARE ASSOCIATED WITH INCREASED RISK OF VENOUS THROMBOEMBOLISM. DATA FROM A LARGE NATIONAL COHORT. IS IT THE MECHANISM OF THE DRUG OR THE DISEASE?
2024
·
Omair Iqbal
, Paraj Patel
, et al.
·
Gastroenterology
Abstract 5084: Epigenetic modifications involving reactivation of RECK inhibiting MMP-9 and MMP-2 in prostate cancer
2019
·
Eswar Shankar
, Omair Iqbal
, et al.
·
Cancer Research
Abstract 5084: Epigenetic modifications involving reactivation of RECK inhibiting MMP-9 and MMP-2 in prostate cancer
2019
·
Eswar Shankar
, Omair Iqbal
, et al.
·
Prevention, Early Detection, and Interception
Mp34-01 Dual Targeting of Ezh2 and Androgen Receptor Synergistically Inhibits Castration-resistant Prostate Cancer
2019
·
Eswar Shankar*
, Daniel Franco
, et al.
·
The Journal of Urology
Abstract 4815: Efficacy and toxicity of combinatorial therapy with EZH2 and androgen receptor inhibitor for castration-resistant prostate cancer
2018
·
Eswar Shankar
, Daniel Franco
, et al.
·
Cancer Research
Show more works
View as search
Works count:
12
Citation count:
42
H-index:
3
I10-index:
1
Year
Topic
Type
